CLINICAL RESOURCES

Contact us at [email protected] or 1-877-409-3629 to ask about our free online webinars on pharmacogenetics.

Pharmacogenetics in Practice

Pillcheck reports on over 50 antidepressants and antipsychotic medications according to FDA drug labels and CPIC guidelines:

Clinical utility of pharmacogenetics in treatment of depression, anxiety and other mental health conditions:

Pillcheck reports on over 15 analgesics including opioid prodrugs, TCAs and SNRIs according to FDA drug labels and CPIC guidelines:

Pillcheck reports on chemotherapy medications according to FDA drug labels and CPIC guidelines:

BREAST CANCER

For women treated with tamoxifen, Pillcheck can help to identify whether a dose increase is warranted for women with reduced CYP2D6 function or if a switch to aromatase inhibitors is needed for women with absent CYP2D6 function. Pillcheck can also identify whether the use of tamoxifen poses a higher risk of thrombosis and stroke for women carrying mutations in F2 or F5 genes as per the FDA drug warning label.

NAUSEA MANAGEMENT

Nausea poses a significant challenge for most cancer patients. Commonly used antiemetics dolasetron, ondansetron, palonosetron and tropisetron are ineffective for people with greatly enhanced CYP2D6 activity. These patients need treatment with alternative antiemetic medications.

Skip to content